State Street Corp Catalyst Pharmaceuticals, Inc. Transaction History
State Street Corp
- $2.8 Trillion
- Q3 2025
A detailed history of State Street Corp transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 6,405,387 shares of CPRX stock, worth $148 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,405,387
Previous 5,478,388
16.92%
Holding current value
$148 Million
Previous $119 Million
6.14%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding CPRX
# of Institutions
394Shares Held
106MCall Options Held
164KPut Options Held
439K-
Black Rock Inc. New York, NY18.7MShares$433 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.71MShares$202 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY4.97MShares$115 Million1.82% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.54MShares$82.2 Million0.1% of portfolio
-
Terry Smith Fundsmith LLP | London, X03.36MShares$78 Million0.34% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.38B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...